Evidence map›Paper›PMID 34260055›Full record

Observational studyInfection2022

Bacterial infections in critically ill patients with SARS-2-COVID-19 infection: results of a prospective observational multicenter study.

Vincenzo De Santis, Alberto Corona, Domenico Vitale, Cecilia Nencini, Antonella Potalivo, Anna Prete, Gianluca Zani, Anna Malfatto, Luigi Tritapepe, Stefania Taddei and 4 more

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Infection, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Antimicrobial Resistance ofAntibiotics (Basel, Switzerland) · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Vincenzo De SantisDepartment of Anesthesia and Intensive Care Medicine, Ospedale Santa Maria Delle Croci, Viale Randi, 5, 48121, Ravenna, Italy. vincenzo.desantis@auslromagna.it.ORCID http://orcid.org/0000-0002-5105-7969
Alberto CoronaEmergency Anesthesia and Intensive Care Medicine Department, Esine and Edolo Hospital, ASST Valcamonica, Brescia, Italy.
Domenico VitaleDepartment of Anesthesia and Intensive Care Medicine, Azienda Ospedaliera Santa Croce e Carle, Cuneo, Italy.
Cecilia NenciniDepartment of Anesthesia and Intensive Care Medicine, Ospedale Santa Maria Delle Croci, Viale Randi, 5, 48121, Ravenna, Italy.
Antonella PotalivoDepartment of Anesthesia and Intensive Care Medicine, Ospedale "Infermi" Rimini, Rimini, Italy.
Anna PreteDepartment of Anesthesia and Intensive Care Medicine, Ospedale Santa Maria Delle Croci, Viale Randi, 5, 48121, Ravenna, Italy.
Gianluca ZaniDepartment of Anesthesia and Intensive Care Medicine, Ospedale Santa Maria Delle Croci, Viale Randi, 5, 48121, Ravenna, Italy.
Anna MalfattoDepartment of Anesthesia and Intensive Care Medicine, Ospedale di Bentivoglio Azienda USL Bologna, Bologna, Italy.
Luigi TritapepeDepartment of Anesthesia and Intensive Care Medicine, Azienda Ospedaliera San Camillo Forlanini, Rome, Italy.
Stefania TaddeiDepartment of Anesthesia and Intensive Care Medicine, Ospedale di Bentivoglio Azienda USL Bologna, Bologna, Italy.
Alessandro LocatelliDepartment of Anesthesia and Intensive Care Medicine, Azienda Ospedaliera Santa Croce e Carle, Cuneo, Italy.
Vittorio SambriUOC Microbiology and Medical Laboratory, AUSL Romagna, Cesena, Italy.
Maurizio FusariDepartment of Anesthesia and Intensive Care Medicine, Ospedale Santa Maria Delle Croci, Viale Randi, 5, 48121, Ravenna, Italy.
Mervyn SingerBloomsbury Institute of Intensive Care Medicine, University College London, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo investigate the prevalence, incidence and characteristics of bacterial infections and their impact on outcome in critically ill patients infected with COVID-19.

methodsWe conducted a prospective observational study in eight Italian ICUs from February to May 2020; data were collected through an interactive electronic database. Kaplan-Meier analysis (limit product method) was used to identify the occurrence of infections and risk of acquisition.

resultsDuring the study period 248 patients were recruited in the eight participating ICUs. Ninety (36.3%) patients developed at least one episode of secondary infection. An ICU length of stay between 7 and 14 days was characterized by a higher occurrence of infectious complications, with ventilator-associated pneumonia being the most frequent. At least one course of antibiotic therapy was given to 161 (64.9%) patients. Overall ICU and hospital mortality were 33.9% and 42.9%, respectively. Patients developing bacteremia had a higher risk of ICU mortality [45.9% vs. 31.6%, odds ratio 1.8 (95% CI 0.9-3.7), p = 0.069] and hospital mortality [56.8% vs. 40.3%, odds ratio 1.9 (95% CI 1.1-3.9), p = 0.04].

conclusionIn critically ill patients infected with COVID-19 the incidence of bacterial infections is high and associated with worse outcomes. Regular microbiological surveillance and strict infection control measures are mandated.

Indexed as

Bacterial InfectionsCOVID-19Critical IllnessHumansIntensive Care UnitsProspective StudiesSARS-CoV-2Co-infectionCOVID-19Critically ill patientsSecondary bacterial infection

Identifiers

PMID34260055
PMCPMC8278178

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.